The role of lipid droplets and adipocytes in cancer. Raman imaging of cell cultures: MCF10A, MCF7, and MDA-MB-231 compared to adipocytes in cancerous human breast tissue

The Analyst
Halina AbramczykKrystyna Fabianowska-Majewska

Abstract

We have studied live non-malignant (MCF10A), mildly malignant (MCF7) and malignant (MDA-MB-231) breast cancer cells and human breast cancer tissue. We demonstrate the first application of Raman imaging and spectroscopy in diagnosing the role of lipid droplets in cell line cultures that closely mimic an in vivo environment of various stages in human breast cancer tissue. We have analyzed the composition of the lipid droplets in non-malignant and malignant human breast epithelial cell lines and discussed the potential of lipid droplets as a prognostic marker in breast cancer. To identify any difference in the lipid droplet-associated biochemistry and to correlate it with different stages of breast cancer, the PCA method was employed. The chemical composition of lipids and proteins, both in the cell line models and in human breast tissue has been analyzed. The paper shows the alterations in lipid metabolism that have been reported in cancer, at both the cellular and tissue levels, and discusses how they contribute to the different aspects of tumourigenesis.

References

Feb 5, 1973·Biochemical and Biophysical Research Communications·K A HartmanG J Thomas
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·S LeikinG E Walrafen
Mar 16, 2000·Journal of the National Cancer Institute·J White
Aug 8, 2002·The Journal of Investigative Dermatology·Annieke NijssenGerwin J Puppels
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Laura L ListenbergerJean E Schaffer
Feb 24, 1956·Science·O WARBURG
Nov 6, 2003·International Journal of Cancer. Journal International Du Cancer·Zhiwei HuangHaishan Zeng
Jul 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Javier A MenendezRuth Lupu
Jul 30, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Pontus BoströmSven-Olof Olofsson
Mar 18, 2006·Molecular & Cellular Proteomics : MCP·Mathias BellerRonald P Kühnlein
Jul 5, 2007·Journal of Proteome Research·René BartzPingsheng Liu
Sep 21, 2007·Nature Reviews. Cancer·Javier A Menendez, Ruth Lupu
Dec 20, 2007·Traffic·Lars KuerschnerChristoph Thiele
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Matthias P Wymann, Roger Schneiter
Jan 1, 2009·Molecular and Cellular Biochemistry·Dawn L BrasaemleAlexis Rothenberg
Mar 9, 2010·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Patricia T Bozza, João P B Viola
Mar 23, 2010·FEBS Letters·Mathias BellerHerbert Jäckle
Apr 7, 2010·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Kent L Erickson, Neil E Hubbard
Jul 19, 2008·Annual Review of Analytical Chemistry·Conor L Evans, X Sunney Xie
Aug 18, 2010·Journal of Lipid Research·Thuc T LeJi-Xin Cheng
Jan 25, 2011·Nature Reviews. Cancer·Rob A CairnsTak W Mak
Apr 12, 2011·Journal of Medicinal Chemistry·Beata Brozek-PluskaHalina Abramczyk
Aug 24, 2011·Journal of Electron Microscopy·Michitaka SuzukiToyoshi Fujimoto
Sep 15, 2011·Cancer Research·Kavita BhallaGeoffrey D Girnun
Nov 22, 2011·Nature·Andrew R MullenRalph J DeBerardinis
Nov 22, 2011·Nature·Christian M MetalloGregory Stephanopoulos
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·David R WiseCraig B Thompson
Nov 30, 2011·Progress in Biophysics and Molecular Biology·Halina AbramczykRadzisław Kordek
May 25, 2012·The FEBS Journal·Claudio R Santos, Almut Schulze
Jul 4, 2012·The Analyst·Beata Brozek-PluskaHalina Abramczyk
Jul 13, 2012·Cancer Research·Nousheen ZaidiKarine Smans
Jan 1, 1996·Journal of Biomedical Optics·A Mahadevan-Jansen, R R Richards-Kortum

❮ Previous
Next ❯

Citations

Feb 24, 2016·Frontiers in Pharmacology·Bassil DekkyHervé Emonard
Jan 26, 2016·Oncogenesis·S Beloribi-DjefafliaF Guillaumond
Oct 19, 2016·Journal of Biophotonics·Evangelia GavgiotakiIrene Athanassakis
Mar 25, 2017·Critical Reviews in Analytical Chemistry·Kamil JurowskiBogusław Buszewski
Jul 7, 2016·Technology in Cancer Research & Treatment·Felicia S ManciuGiulio Francia
Nov 22, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Julien A MenardMattias Belting
May 15, 2018·Integrative Biology : Quantitative Biosciences From Nano to Macro·Stefano FornasaroValter Sergo
Aug 17, 2018·Bioscience Reports·Peter ShyuGuillaume Thibault
Oct 28, 2019·Stem Cells·Malini VisweswaranArun Dharmarajan
Feb 18, 2020·International Journal of Cancer. Journal International Du Cancer·Bernhard EnglingerWalter Berger
Sep 27, 2019·Scientific Reports·Tiffany Guerenne-Del BenJean-Michel Petit
Oct 2, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Fei ZhangBin Liu
Apr 8, 2017·Cell Death Discovery·Johannes BischofMark Rinnerthaler
Apr 28, 2017·Frontiers in Oncology·Seema GuptaBilikere S Dwarakanath
Dec 21, 2018·Cancer Metastasis Reviews·Gregory W AunerMichelle A Brusatori
Jul 18, 2018·Frontiers in Endocrinology·Guojing LuoXijie Yu
Apr 17, 2020·Frontiers in Oncology·Xiangyu SunYingying Xu
Oct 11, 2017·Cellular Oncology (Dordrecht)·Trang H LuuHassan Nazih
Sep 21, 2018·Materials·Tkhe Kyong FamMayeul Collot
May 28, 2020·Biomolecules·Rumiana TzonevaSalvatore Chiantia
Aug 15, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Francesca NardiSusan E Crawford
Jul 4, 2018·International Journal of Molecular Sciences·Andrea AntonosanteAnnamaria Cimini
Jul 14, 2018·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Bartosz PolisHalina Abramczyk
May 21, 2019·NMR in Biomedicine·Sean Philip ArlauckasEdward James Delikatny
Sep 16, 2020·Science China. Life Sciences·Phei Er SawEr-Wei Song
Dec 19, 2019·Cancers·Halina AbramczykAgnieszka Śliwińska
Aug 24, 2018·Scientific Reports·Jakub M SurmackiSarah E Bohndiek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.